Pages that link to "Q34218728"

The following pages link to How much phenotypic variation can be attributed to parkin genotype? (Q34218728):

Displaying 50 items.

• Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell death (Q24313820) (← links)
• Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity (Q25256506) (← links)
• Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives (Q26747508) (← links)
• The role of free radicals in the aging brain and Parkinson's Disease: convergence and parallelism (Q26852148) (← links)
• The genetics and neuropathology of Parkinson's disease (Q26859945) (← links)
• Parkin deficiency delays motor decline and disease manifestation in a mouse model of synucleinopathy (Q28475940) (← links)
• Parkin-deficient mice are not a robust model of parkinsonism (Q28504677) (← links)
• Parkin disease: a clinicopathologic entity? (Q30594306) (← links)
• Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism (Q33393439) (← links)
• Olfaction in Parkin carriers in Chinese patients with Parkinson disease (Q33695309) (← links)
• Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method (Q33721033) (← links)
• Role of mendelian genes in "sporadic" Parkinson's disease (Q34240463) (← links)
• Genetics of parkin-linked disease. (Q34290333) (← links)
• Genetics of Parkinson's disease: the yield (Q34386808) (← links)
• Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity (Q34528753) (← links)
• Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. (Q34555482) (← links)
• Deletion of the parkin and PACRG gene promoter in early-onset parkinsonism (Q34577165) (← links)
• Diagnosis and treatment of Parkinson disease: molecules to medicine (Q34698876) (← links)
• The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study (Q35054613) (← links)
• The relation between depression and parkin genotype: the CORE-PD study (Q35566358) (← links)
• Pathogenetic mechanisms of parkin in Parkinson's disease (Q35869639) (← links)
• Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study (Q35898027) (← links)
• PINK, PANK, or PARK? A clinicians' guide to familial parkinsonism (Q35920094) (← links)
• Genetic testing in Parkinson's disease (Q35927013) (← links)
• Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism (Q36424540) (← links)
• Recessive Parkinson's disease (Q36449306) (← links)
• Parkinson's disease: the genetics of a heterogeneous disorder (Q36516918) (← links)
• The genetics of Parkinson disease: Implications for neurological care (Q36577255) (← links)
• Analysis of PRKN Variants and Clinical Features in Polish Patients with Parkinson's Disease (Q36613028) (← links)
• The genetics of Parkinson's disease: progress and therapeutic implications (Q36626825) (← links)
• Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease (Q36761674) (← links)
• Pathogenic mutations in Parkinson disease (Q36770206) (← links)
• Molecular imaging in hereditary forms of parkinsonism. (Q36771898) (← links)
• Deciphering the role of heterozygous mutations in genes associated with parkinsonism (Q36854642) (← links)
• Genomic mechanisms underlying PARK2 large deletions identified in a cohort of patients with PD. (Q36868772) (← links)
• The parkin protein as a therapeutic target in Parkinson's disease (Q37004729) (← links)
• Genetics of Parkinson disease (Q37037053) (← links)
• Mitochondria in the aetiology and pathogenesis of Parkinson's disease (Q37037953) (← links)
• Review: Familial Parkinson's disease--genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease (Q37151410) (← links)
• A multidisciplinary study of patients with early-onset PD with and without parkin mutations (Q37180446) (← links)
• Targets for neuroprotection in Parkinson's disease (Q37302453) (← links)
• Gene Therapy: A Promising Approach for Neuroprotection in Parkinson's Disease? (Q37516424) (← links)
• Cognitive and motor function in long-duration PARKIN-associated Parkinson disease (Q37625797) (← links)
• Molecular mechanisms of pathogenesis of Parkinson's disease. (Q37749063) (← links)
• Pallidopyramidal disease: a misnomer? (Q37772452) (← links)
• Rare causes of dystonia parkinsonism (Q37778764) (← links)
• Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease (Q37809751) (← links)
• Parkin, A Top Level Manager in the Cell's Sanitation Department (Q37883939) (← links)
• Autosomal recessive parkinsonism (Q37968072) (← links)
• The significance of neuronal lateralisation in Parkinson's disease (Q37988384) (← links)